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Cognitive-Educational Treatment of Fibromyalgia: 
A Randomized Clinical Trial. I. Clinical Effects
JOHAN W.S. VLAEYEN, NICOLE J.G. TEEKEN-GRUBEN, MARIËLLE E.J.B. GOOSSENS,
MAUREEN P.M.H. RUTTEN-van MÖLKEN, ROB A.G.B. PELT, HUGO van EEK, and PETER H.T.G. HEUTS
ABSTRACT, Objective. This randomized controlled clinical trial evaluates the effectiveness of outpatient group
cognitive/educational treatment for patients with the fibromyalgia (FM) syndrome. We hypothe­
sized that the combination of group education with cognitive treatment aimed at developing pain 
coping skills would be more effective than group education alone.
Methods. 131 patients with FM were randomly assigned to 3 conditions: an experimental condition, 
which was the combined cognitive/educational intervention (ECO); an attention control condition 
consisting of group education plus group discussion (EDI); and a waiting list control (WLC). For 
the treatment conditions ECO and EDI, assessments were made 2 weeks before treatment, at start 
of treatment, at post-treatment, and at 6 and 12 mo follow up. WLC patients received only 3 assess­
ments.
Results. There were no pretreatment differences between the groups, or between dropouts and 
patients who remained in the study. At post-treatment, and compared with the WLC, the ECO 
patients improved in knowledge about FM (p = 0.007) and pain coping (p < 0.001). EDI patients 
improved on pain coping (p = 0.005) and pain control (p = 0.002). EDI patients reported signifi­
cantly less fear than ECO patients (p= 0.005). There were no other differential effects between ECO 
and EDI at post-treatment or 6 mo or 12 mo followup. Based on the reliability of change index for 
clinical significance, the relative short term success rates are 6.4 and 18.4% for ECO and EDI, 
respectively.
Conclusion. The surplus value of a highly structured, 12 session group cognitive treatment added to 
group education cannot be supported by our study. In EDI, fear reduction might have enhanced pain 
coping and pain control, while poor compliance, the difficulty of homework assignments, and lack 
of individual support may have limited the effectiveness of ECO. (J Rheumatol 1996;23:1237-45)
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PAIN TREATMENT PSYCHOLOGICAL TREATMENT CLINICAL SIGNIFICANCE
Fibromyalgia (FM) syndrome is a common chronic muscu­
loskeletal pain syndrome, characterized by generalized pain 
and the presence of a predictable pattern of musculoskeletal 
“tender points.” Following the Am erican College of 
Rheumatology (ACR) diagnostic criteria for F M 1, digital 
palpation of the majority of these tender points causes 
hyperalgesia, while palpation of control points fails to pro­
duce exaggerated sensitivity. FM is considered a common
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chronic pain syndrome in The Netherlands2-4, although 
prevalence and incidence rates are not available yet. The 
pathophysiology of FM  is still unknown. Studies focusing 
on possible associations with sleep disorders5, muscle dis­
ease6, pain modulation disturbances7, and psychopatholo­
gy8*9 remained inconclusive. A more promising research 
area concerns the role of neuroim m unological changes asso- 
ciated with F M 10. From a biopsychosocial or behavioral 
approach, pain disability is determined not only by an 
underlying pathology, but also by emotional, cognitive, and 
environmental factors11 ’12. Cognitive-behavioral interven­
tions are aimed at teaching patients the skills necessary to 
control pain and disability, and building their confidence 
that they can successfully use these skills in their daily lives. 
Only a few studies have evaluated the effectiveness of cog­
nitive-behavioral interventions for FM. Haanen et a l13 com­
pared hypnotherapy with traditional physiotherapy. In com­
parison with the physiotherapy group, patients who received 
hypnotherapy improved on self-report measures of pain, 
fatigue, sleep habits, and a global assessment. Using a pseu­
do-experimental design, Nielson, e t  a lXA evaluated a 3 week 
inpatient cognitive-behavioral program  composed of a set of
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interventions directed toward the sensory, affective, cogni­
tive, and behavioral components of chronic pain, based on 
treatment protocols described by Turk, et a l xK Comparison 
o f pre and post-treatm ent scores revealed significant 
improvements on all target outcome measures the program 
had addressed, while no significant changes were found for 
the non-target outcome measures that were included. A 
recent longterm followup assessment (at a mean of 30 
months after discharge) revealed significant improvement 
on 3 of the 10 target variables15. The authors concluded that 
randomized controlled trials are needed to demonstrate the 
effectiveness o f cognitive-behavioral treatment, alone or in 
combination with other treatments. B radley12 presented an 
experimental design that may be used in randomized, con­
trolled clinical trials of cognitive treatment in patients with 
FM. He also discussed cognitive-behavioral treatment pro­
cedures that can be applied to patients with FM.
Our aim was to evaluate the effectiveness of outpatient 
educational-cognitive group treatment for patients with FM, 
following suggestions made by Bradley12. Specifically, we 
hypothesized that the combination of cognitive treatment 
with group education would be more effective than group 
education alone on measures of pain coping strategies, pain 
control, tension levels, quality o f life, and health care uti­
lization. Compared to a waiting list condition, both inter­
ventions are additionally hypothesized to show improve­
ment on knowledge related to the information provided in 
the educational program. Our results are presented in two 
parts. Part I describes the study design, subject characteris­
tics, treatment ingredients, and results of the clinical evalu­
ation. Part I I16 focuses on the economic evaluation, includ­
ing assessments of direct and indirect costs, utilities and 
cost-effectiveness.
MATERIALS AND METHODS
Subjects. Two hundred ninely subjects were referred by die department o f 
rheumatology of a regional general hospital, of whom 131 both signed the 
informed consent form and met the inclusion/exclusion criteria. To carry 
out the study as “blind” as possible, patients were only given the general 
information that the 3 treatment conditions were quite similar, except for 
the treatment component given by the psychologist. Criteria for acceptance 
into the study were that subjects meet the ACR criteria for FM as described 
by Wolfe, et a l\  and be between 18 and 65 years of age. Exclusion criteria 
were illiteracy, pregnancy, substance abuse, involvement in any litigation 
concerning disability income, specific medical disorders and diseases m ak­
ing immediate medical treatment necessary (e.g., infectious diseases, frac­
tures) or preventing subjects performing physical exercise (e.g., cardiovas­
cular diseases), the use of supportive equipment for ambulation, and severe 
psychopathology that would make the patient unable to participate in a 
group format. The diagnosis according to the ACR criteria was made by the 
referring rheumatologists. Preset criteria applied to 2 standardized tests, the 
SCL-9017 and the Dutch Personality Questionnaire18, were used to exclude 
patients whose level o f  psychopathology was expected to interfere with 
group participation.
O f 131 patients, 49 were randomly assigned to the educational-cogni­
tive group (ECO), 39 to the educational discussion group (EDI), and 43 
patients to the waiting list condition (WLC). Six patients dropped out just 
after the randomization, 3 from the ECO group and 3 from the W LC con­
dition. These patients had changed their minds about participation and 
could not be included in further analyses. Patients in the 3 conditions did 
not differ on demographic variables as tested by chi-squared analyses and 
univariate analysis of variance (p > 0.289). The total group consisted of 
12% male and 88% female patients with a mean age o f  44 years (Table I).
Table /. D em ographic characteristics o f  the study sample (n = 125).
Variable Total ECO EDI W LC P
A ge (yrs)» mean (SD) 44.0 (9.4) 44.6 (9.3) 44.6 (9.6) 42.8 (9.6) 0.515
A ge o f  pain onset (yrs), 
m ean (SD) 33.7 (9.9) 34.5 (9.2) 33.9(11.4) 32.8 (9.2) 0.626
Pain duration (yrs), 
m ean (SD) 10.2 (8.1) 10.4(7.7) 10.2 (8.8) 9.9 (7.9) 0.902
Sex {%) 
Fem ale 88 93 87 82
0.289
M ale 12 7 13 18
Education (%)* 
Primary 90.0 93.3 88.9 87.2
0.799’*
Secondary 5.8 4.4 2.8 10.3
A dvanced 4.2 2.2 8.3 2.6
Work status (%) 
Paid work 25.7 34.1 17.6 23.7
0.559
No disability incom e/ 
no paid w ork 28.3 19.5 38.2 28.9
U nem ploym ent/ 
retirem ent benefits 8.8 9.8 5.9 10.5
Sickness/disability  benefits 37.2 26.6 38.2 36.8
* Primary: 6 years o f primary school starting at age 6 with no more than 4  additional years o f  education. 
Secondary: 6 years o f  primary school w ith  minimum 4  of additional education and maximum 6 years of high 
school education. Advanced: Academ ic or advanced non-academic education.
“ B ecause of excessive num ber o f  cells with expected frequency < 5, the chi-squared test was carried out on a 
dichotom ized variable (primary versus secondary/advanced).
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The patients had longstanding pain problems (35.2% for > 10 years). The 
average time since the onset of the pain complaints was 10.2 years (SD = 
8 .1 ). Of the total sample, 90% had lower levels of education (< 10 years of 
education starting at age 6 ), 78.7% were unemployed, and 48.9% received 
financial benefits or disability compensation. Although there were relative­
ly more patients with paid work in the ECO condition compared to the EDI 
condition, the difference in work status between these groups was not sig­
nificant (p= 0.296).
Study design. Before starting the pretreatment assessments, patients were 
randomly assigned to an educational-cognitive condition, an educational 
discussion condition, or to a waiting list condition. The ECO condition was 
designated the treatment condition, and the other 2  were included as con­
trol conditions: EDI as an attention control condition to control for the non­
specific effects of the cognitive treatment, and the WLC condition to con­
trol for natural history effects. A repeated measurements design was cho­
sen, consisting of 2 measurements before treatment (PRE1 and PRE2) 
spaced at 2  week intervals, one measurement after treatment (POST), a 6  
month foUowup (FUI), and a 12 month followup (FU2) assessment. As it 
was not possible to withhold treatment for too long, patients assigned to the 
WLC group received 3 measurements (PREI, PRE2, and POST), and were 
followed for a period of 8  weeks only. After the waiting period they 
received outpatient rehabilitation treatment.
Treatments. The outpatient treatments were highly structured and were con­
ducted in a group fornì at, with a maximum of 6  patients per group. The 
treatment consisted of 12 sessions spread over 6  weeks.
Educational program. The educational program, which was applied to both 
ECO and EDI, consisted of twelve 2 hour sessions, each session conducted 
by one member of the interdisciplinary rehabilitation staff. The program 
was intended to provide information about psychosocial factors that influ­
ence pain, ergonomic principles applied to daily activities, and social secu­
rity legislation. The information did not only focus on FM specifically, but 
also on chronic pain in general. Each session ended with a physical exer­
cise, such as swimming or bicycling, excluding systematic physical or fit­
ness training.
Cognitive treatment. The cognitive treatment was aimed at decreasing dis­
torted pain attributions and at increasing self-efficacy expectations. This 
group program consisted of 12 sessions of 90 minutes, grouped into 3 phas­
es: a reconceptualization phase, a skills acquisition phase, and a general­
ization phase. The goal of the reconceptualization phase was to modify the 
pain experience in terms that imply self-control and resourcefulness. In the 
skills acquisition phase, patients practised 2  types of imagery: imaginative 
transformation of the pain sensation and pain-incompatible sensory 
imagery. These techniques were drawn from Diamond19 and Fernandez20. 
In addition, the Applied Relaxation (APR) technique21 was used and sup­
ported by electromyography (EMG) biofeedback. The EMG feedback was 
applied to all patients of the group at the same time, by the same psychol­
ogist, and was employed mainly to help patients recognizc muscle tension 
and relaxation. In the reconceptualization phase, the role of muscle tension 
in the maintenance of the pain problem is highlighted. By means of EMG 
biofeedback the patient is encouraged to identify tension eliciting stimuli 
and to differentiate between muscle tension and relaxation. During the 
skills acquisition phase, the patient is taught the relaxation response accord­
ing to the APR. During the generalization phase, the patient is gradually 
exposed to tension eliciting stimuli, and encouraged to use the relaxation 
skills in the presence of these stimuli.
At the end of each session patients are supplied with texts to read, or a 
tape to listen to at least once a day. During the generalization phase the 
patients are asked to evaluate the different exercises. This information is 
then used to design an individually tailored audiotape the patient can use 
after discharge. Throughout the program, patients are given homework 
assignments each session. These consisted of brief relevant reading assign­
ments and audiotaped practice exercises based on the techniques taught 
during the sessions. Patients were requested to complete specially designed 
homework sheets after termination of each assignment. The cognitive treat­
ment was conducted by one of the psychologists, a behavior therapist with
10 years’ experience in cognitive behavior therapy for chronic pain.
Group discussion (attention control). To provide an attention control to 
compare with the cognitive treatment, a group discussion program was 
developed, during which patients were requested to read parts of a book 
about pain, written for pain patients, and to then share the information and 
their own thoughts with the other group members. In addition, participants 
listened to various audiotaped music fragments. Each session ended with a 
homework assignment, consisting of brief relevant reading assignments 
and listening to audiotaped musical fragments. The group discussion was 
conducted by the same psychologist who was in charge of the cognitive 
treatment, and consisted of the same number of sessions. Hence, neither the 
subjects nor the therapists of the interdisciplinary rehabilitation staff in 
charge of the educational program were aware of the difference between 
the 2  treatments.
Treatment credibility. Differential treatment credibility was assessed fol­
lowing the procedure described by Borkovec and Nau22. Before the start of  
the cognitive treatment and the group discussion, patients were given a 
written description of the goals and contents' o f the respective treatments. 
During the first session this material was discussed and patients had an 
opportunity to ask questions. When these questions had been answered, the 
patients were given a visual analog scale on which they could indicate to 
what extent they believed that the treatment was going to be helpful in 
learning to cope with the complaints.
Outcome measures. We chose a comprehensive set o f pain measures for the 
motoric and verbal-cognitive aspects o f pain. The measures were selected 
to represent a balanced series o f the most meaningful, reliable, and valid 
variables. The aim was to select a set of measures that would be at least 
mutually intercorrelated for subsequent analyses23. As suggested by Kerns, 
et al24, a principal component analysis with oblique rotation was applied on 
the pretreatment dat^ set (the means of PRE1 and PRE2)*. After transfor­
mation into sLandard z scores, composite scores were defined. This strate­
gy has the advantage of aggregating measures that are correlated, produc­
ing a smaller set o f more reliable composite scores2-“5. Based on the eigen­
value > 1 criterion, the component analysis revealed 7 relatively indepen­
dent components. These accountcd for 75.4% o f  the total variance in the 
original measures. Components were labeled as follows: catastrophizing, 
pain coping, activities, pain behavior, pain control, pain intensity, and 
relaxation (Table 2). In addition, the Dutch Hyperventilation Questionnaire, 
a recognized self-report measure for subjective tension, and a test for FM 
knowledge were administered. Affective distress measures were the Fear 
Survey Schedule (FSS-III-R)37, the Beck Depression Inventory (BD1)-1\  
and the Maudsley Obsessive Compulsive Inventory (MOCI)34,40. To control 
for test-taking attitude, a scale for Social Desirability41'42 was added. One 
recent study showed that patients with FM have elevated scores on a mea­
sure of social desirability, and that they score significantly higher than 
patients with chronic low back pain4-1.
Three groups of variables are distinguished: primary outcome variables, 
which are expected to be affected directly by the treatment program (pain 
coping, relaxation, tension, pain control, and knowledge), secondary out­
come variables, which are not expected to be directly affected by the pro­
gram (pain intensity, catastrophizing, pain behavior, and activities), and 
affective variables, which the treatment program was not directly intended 
to change (fear, depression, and obsessive compulsiveness). Quality of life 
measures, as well as measures o f direct and indirect costs, are included in 
Part II o f  this study16.
Statistical procedure. Within-group analysis was carried out with multi­
variate analysis of co variance for repeated measures with social desirabili­
* As such a component analysis theoretically can interfere negatively with 
appropriate tests o f the hypotheses, the measures for “tension” and “know­
ledge” were treated separately. These variables were also considered to 
overlap minimally with other measures. Similarly, measures of affective 
distress (fear, depression, and obsessive compulsivity) were also excluded 
from the component analysis.
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Table 2. Composite variables derived from a principal component analysis with oblique rotation. Components 
with composing variables with loadings, percentage explained variance, and Cronbach’s alpha of respective com­
ponents.
Component Loading Percentage of 
Explained Variance
Alpha
Catastrophizing 19.8 0.74
PCL: Catastrophizing 0.61
PCL: Pain impact 0.78
CSQ: Catastrophizing 0.83
CSQ: Praying and hoping 0.48
Pain coping 17.5 0.82
CSQ: Attention diversion 0.74
CSQ: Reinterpreting pain 0.71
CSQ: Ignoring pain 0.81
CSQ: Positive self-talk 0.61
CSQ: Increasing activities 0.80
Activity level 13.2 0,84
BAT: Distance walking 0.89
BAT: Time walking 0.92
BAT: Time bicycling 0.58
Pain behavior 8 .1 0.84
UAB: Total score 0 .8 8
CHIP: Distorted mobility 0 . 8 8
CHIP: Nonverbal complaints 0.87
BAT: Time replacing objects 0.45
Pain control 6.5 0,65
CSQ: Perceived pain control 0.82
MPLC: Internal locus 0.89
Pain intensity 5.6 0.96
MPQ: Number of words chosen -0.98
MPQ: Present rating intensity -0.91
Relaxation 4.7 —
CSQ: Relaxation -0.63
PCL: Pain Cognition Lisi26. CSQ: Coping Strategies Questionnaire27-28. BAT: Behavioral Approach Test29,30. 
UAB: Pain Behavior Scale31,32, CHIP: Checklist for Interpersonal Pain Behavior33, MPLC: Multidimensional 
Pain Locus of Control scale34. MPQ: McGill Pain Questionnaire35,36.
ty as a covariate. This analysis was done to examine differences between 
PRE-POST, PRE-FU1, and PRE-FU2 for each dependent variable, and for 
each group separately. To test the null hypothesis that the experimental 
treatment was not better than Lhe control conditions, we did analysis of 
co vari ance (ANCO VA) on the post-treatment, 6  month, and 12 month fol- 
lowup data for each dependent variable, with the pretreatment data and the 
social desirability score as covariates. This procedure controls for pretreat­
ment differences on the dependent variables and social desirability. The 
independent variable is the experimental condition (ECO, EDI, or WLC). 
To avoid an excessive Type I error rate, the Bonferroni correction method 
was applied to each group of variables. Given that there were 5 variables in 
the largest group of primary outcome variables, a p value less than 0 .0 1  
(0.05 divided by 5) was considered statistically significant. It was consid­
ered that a more conservative correction would increase the likelihood of 
Type II errors.
Clinical significance. To assess the clinical significance of the magnitude 
of change, the reliability of change (RC) index44"46 is computed as an effect 
size measure. For each patient and for each outcome variable the RC index 
can be calculated as follows: RC = (x2 -  x,)/SdUp where x l represents the 
pretreatment score and x3 the post-treatment score. Sdjfï is the standard error 
of the difference between the 2  scores, which provides a measure of the 
spread of the distribution of change scores that would be expected if no 
actual change in scores occurs. Sdify can also be calculated as V2(SE)2, where 
SE = SjVl-rxx. In this formula, s, represents the standard deviation of the 
pretreatment scores, and r the test-retest reliability of the measurement
A  A
instrument. If RC exceeds 1.95, the magnitude of change can be considered 
more than the normal measurement fluctuations that occur with repeated 
measurements. If RC < -1.96, there has been a significant clinical decline.
RESULTS
Attrition. Of 125 patients who started treatment, results were 
available from 112 (90%) at post-treatment, 67 (79%) at 6 
month followup, and 66 (78%) at 12 month foliowup. The 
attrition rates were 22 , 23, and 2.5% for the ECO, EDI, and 
WLC groups, respectively The small number of dropouts 
from the WLC condition reflects the much shorter followup 
period (8 weeks) and the patients’ anticipation of treatment 
after the 8 week waiting period. One group of 6 patients of 
the ECO condition was discontinued by the treatment staff 
after about 3 weeks of treatment because of group cohesion 
difficulties. Other reasons for dropout were absence during 
more than 3 consecutive sessions (ECO:3, EDI:1), refusal to 
comply with assessments (EDI:4, WLC:1), worsening of 
health condition (ECO:l, EDI: 2 ), death of a family member 
during treatment (EDI: 1), and discontent with program con­
tent (EDI:1). The 20 patients (16%) who dropped out did not 
differ from the remaining patients on biographical variables,
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age, sex, education level, pain duration, or IQ (p > 0.270),
Differential treatment credibility. Although credibility rat­
ings for the cognitive treatment were somewhat higher than 
those of the group discussion (7.0 versus 6.2), this differ­
ence was not statistically significant (p = 0.058). It seems 
justified to conclude that the initial perceptions of the con­
trol patients concerning the potential efficacy and credibili­
ty of the attention control intervention were comparable to 
those of the patients who received the experimental condi­
tion.
Immediate treatment effects. Within-group analyses showed 
that favorable PRE-POST changes are found for both ECO 
and EDI, but not for WLC (Table 3). Separate univariate 
ANC OVA, however, reveal that a significant difference 
among the 3 conditions was found for only 2 primary vari­
ables, “pain coping” and “pain control.” A marginally sig­
nificant difference was also found for the variable “knowl­
edge.” Subsequent pairwise ANCOVA showed there were 
no significant differences between ECO and EDI for these 
variables. For the variable “pain coping,” both ECO and 
EDI are significantly different from WLC (ECO-WLC: p = 
0.000; EDI-W LC, p = 0.005). For “pain control,” a signifi­
cant difference was found only between EDi and WLC (p =
0.002). EDI did significantly better than WLC on the vari­
able “knowledge” (p = 0.007). No secondary variable 
reveals significant effects. Finally, on the variable “fear,” 
there was a significant difference between ECO  and EDI (p 
= 0.005) in favor of EDI, but not between EDI and WLC (p 
= 0,014) or ECO and W LC (p = 0.553).
Pretreatment to longterm fo llow up.  Within-group analyses 
reveal that more significant changes for both ECO and EDI 
occur at the 12 month followup, as compared to the 6 month 
followup assessment (Table 4). Notable is the significant 
increase in pain intensity for ECO at 12 month followup. No 
significant differences, however, are found between the con­
ditions ECO and EDI for any variables of both followup 
assessments, suggesting there are no differential effects 
between ECO and EDI.
Clinical significance. On the basis o f the RC index, patients 
can be classified in categories (positive responders, nonre­
sponders, ambiguous responders, and negative responders) 
related to the number of primary variables on which a clini­
cally significant change is seen (RC > 1.96 and < -1.96).
Table 3. Means (M), standard deviations (SD), and p values for ANCOVA on post-assessment. For variables 
knowledge, pain coping, pain control, relaxation, and activity, high values mean desirable. For the remaining 
variables, high values mean undesirable.
ECO EDI WLC
PRE POST* PRE POST* PRE POST* p**
Primary variables
KnowledgeECO,EDI M 1 1 .8 14.3 11,7 14.3 1 2 .0 12.4 0 . 0 1 0
SD 2.9 2.9 3.0 2,9 3.1 2.9i
Pain copingECO M 0.5 1.3 0 . 2 1 2 .2 - 0 .6 - 1 .0 0 . 0 0 1
SD 3.3 2.7 4.6 2.7 3.6 2.7
Pain controlEC0, EDI M - 0 .1 0.9 - 0 .2 1 .6 0.3 0.4 0.003
SD 1.7 1.4 1.7 1.4 1.8 1.4
Relaxation50* M 42.2 46.7 39.2 43.7 43.5 41.5 0.014
SD 8.5 7.3 12.1 7.3 9.2 7.3
Tension M 31.5 30.6 29.8 28.4 29.3 30.6 0.296
SD 9.5 6 .0 1 0 .0 6 .0 9.6 6 . 0
Secondary variables
Catastrophizing M - 0 . 0 -0.4 - 0 .2 - 1.1 0 .1 -0 .4 0.369
SD 2.5 2 .0 3.5 2 . 0 3.1 2 . 0
Pain intensity M 0 .1 1 .0 - 0 .1 0.4 0 .0 0.4 0.337
SD 2.4 1.8 1 .8 1 .8 1 .6 1 .8
Pain behaviorEC0, EDI M 0 . 2 -1.9 - 0 .2 -1.5 - 0 .2 -0 .7 0.023
SD 4.0 1.6 3.0 1 .6 3.0 1 .6
Activity
%
M 0 .2 0.3 - 0 .1 -0.5 - 0 .1 0 . 2 0.189
SD 2 .6 1.7 2.4 1.7 2.9 1.7
Affective variables
Obsessive-compulsive M 6.3 7.3 5.7 5.8 6 .2 6.4 0.234
SD 5.2 3.3 5.2 3.33 4.5 3.3
FearEDI M 127.6 127.8 127.8 108.4 126.2 123.3 0.009
SD 36.7 21.5 42.8 21.5 44.0 21.5
Depression M 1 2 .8 13.4 12.5 11.9 15.5 13.2 0.566
SD 6 .6 5.8 9.4 5.8 8.3 5.8
* For the PO ST-assessment data, means (M) are corrected for PRE-assessment and social desirability, and stan­
dard deviations (SD) are estimated on the root mean square residual. **p values for ANCOVA with PRE-assess- 
ment and social desirability as covariates.
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Table 4. Means (M), standard deviations (SD), and p values for ANCOVA on 12 month followup assessment. For variables knowledge, pain coping, pain con 
trol, relaxation, and activity, high values mean desirable. For the remaining variables, high values mean undesirable.
PRE
ECO
FUI* FU 2* PRE*
EDI
FU1* FU2* Pf
Primary variables
Know led geECO 1 ’GDI1 •liC02-EDl2 M 1 1 .8 13.4 14.2 11.7 14.1 14.6 0.558 0.584
SD 2.9 2 .6 2 .6 3.0 2 .8 2 .6
Pain coping M 0.4 0.7 1.5 0 .2 0 .1 0.1 0.822 0.140
SD 3.3 3.4 3,1 4.6 3.4 3.1
Pain con trolEC02’ E[JI2 M - 0 .1 0 .6 0 .8 - 0 .2 0 .8 1.0 0.907 0.781
SD 1.7 1.7 1.7 1.7 1.7 1.7
Relaxation M 42.2 47.6 47.1 39.2 39.3 42.2 0.043 0.038
SD 8.5 9.2 7.6 12.1 9.2 7.7
Tension M 31.5 31.5 30.1 29.8 30.4 30.6 0.757 0.819
SD 9.5 6 . 8 7.8 1 0 .0 6 .8 7.8
Secondary variables
Catastrophizi ngHDl2 M - 0 . 0 -0.7 0 .1 - 0 .2 - 1 .2 -1.5 0.549 0 . 0 1 2
SD 2.5 2.3 2.1 3.5 2.3 2 .1
Pain intensityEC02 M 0 .1 1.1 1.0 - 0 .1 0 .1 0 .8 0.024 0.709
SD 2.4 1.7 1.9 1.8 1.7 1.9
Pain behaviorEDI2 M 0 . 2 - 1 .0 - 1.8 - 0 .2 - l . l - 2 .0 0.598 0.862
SD 4.0 2.1 2 .0 3.0 2 .1 2 .0
Activity M 0 . 2 0.1 1 .0 - 0 .1 0 .2 0 .8 0.643 0.673
SD 2 . 6 2.3 1.9 2.4 2.3 1.9
Affective variables
O bses s i v e- co m pu ! si ve M 6.3 6.4 6.9 5.7 5.5 7.1 0.768 0.777
SD 5.2 3.0 2.9 5.2 3.0 2.9
Fear M 127.6 130.4 123.0 127.8 115.8 119.8 0.145 0.605
SD 36.7 17.7 18,5 42.8 17.7 18.5
Depression M 1 2 .S 12.8 14.5 12.5 12.9 13.0 0.742 0.629
SD 6 . 6 6 ,8 1 0 .6 9.4 6 .8 1 0 .6
* For both followup assessments, means (M) are corrected for PRE-assessment and social desirability, and standard deviations (SD) are estimated by root 
mean square residual.
** p values of ANCOVA on FUJ data and f FU2 data with PRE-assessment and social desirability as covariates. 
eco  i , edi i ancj ECO2.E012 s ig n i f ic a n t  within-group effects for FUI and FU2 respectively (p < 0.01).
Positive responders are those with significant Improvement 
on at least one variable, and no decline on any variable. 
Nonresponders are patients with no improvement or decline 
on any variable. Negative responders have a decline on at 
least one variable, and no im provem ent on any o f  the vari­
ables. Ambiguous responders show a decline on at least one 
variable and improvement on at least one other. Table 5 
shows the percentages of patients in each o f these categories 
per experimental condition at post-treatment and at both fol­
lowup assessments. When the ratios o f positive responders 
versus other categories are compared across the experimen­
tal conditions (Figure 1), the only significant difference is in 
the post-treatment data (chi-squared; p = 0.047). Further 
analyses indicate that this effect is due to a significant dif­
ference between EDI and W LC (chi-squared; p = 0.014). It 
is interesting that patients who received no treatment at all 
show a stable pattern, but as Fels on and Goldenberg47 
reported, seem to experience remissions (17.5%) and exac­
erbations ( 10%) over the short followup period o f 8 weeks. 
W hen the percentage of positive responders in the WLC 
condition is extracted from the percentages o f  positive
responders in ECO and EDI, the relative short term success 
rate is 6.4 and 18.4% for ECO and EDI, respectively. Once 
again, EDI does better than ECO, although the success rates 
for both interventions are low.
DISCUSSION
In this randomized clinical trial, comparison is made 
between group education with cognitive treatment (ECO), 
group education with discussion (EDI), and a waiting list 
control (WLC). The 3 groups were comparable on demo­
graphic variables. The patients with FM were moderately to 
severely disabled: the majority of patients had suffered pain 
for about 10 years, were unemployed, and were fearful. It 
may be that the referring rheumatologists of the regional 
hospital consciously or unconsciously sent patients with 
more severe disease, or with more striking pain behaviors. 
For the sample as a whole, very little improvement was 
found. Contrary to the hypothesis, the patients of the EDI 
condition did somewhat better than those who received the 
ECO treatment. They reported an increase in pain coping 
and pain control, but no increase in knowledge about FM.
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Table 5. Distribution of patients (percentages) by response categories for the primary variables (pain coping, pain 
control, relaxation, tension, and knowledge).
ECO
POST
EDI WLC
FUI
ECO EDI
FU2
ECO EDÏ
Negative responders 6.5 2 . 6 1 0 .0 4.3 10.3 6.5 7.7
Nonresponders 47.8 35.9 67.5 43.5 35.9 21.7 33.3
Positive responders 23.9 35.9 17.5 2 1 . 8 28.2 28.2 18.0
Ambiguous responders 2 .2 5.1 2.5 0 .0 5.1 2 . 2 5.1
Dropouts 19.6 7.7 2.5 21.7 20.5 21.7 23.1
Missing values 0 . 0 1 2 .8 0 .0 8.7 0 .0 19.7 1 2 .8
%
50
•-ft:*:*:-.
I • I A •
• * * 9 « ►
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Figure /. Percentage of positive responders, based on primary variables, 
for the ECO (■), EDI (□), and WLC (Ü ) conditions over time.
This is unexpected, as the EDI intervention did not include 
treatment components that were aimed at teaching coping 
skills or self-control techniques. On the other hand, an 
increase in knowledge was expected, as the main ingredient 
of the EDI condition was providing information. As hypoth­
esized, an increase in pain coping and knowledge about FM 
was found in the ECO condition. However, a number of 
expected improvements (such as an increase in pain coping 
and relaxation, and a decrease in tension symptoms) did not 
occur. This is remarkable, as the cognitive ingredient of the 
ECO treatment was aimed at teaching specific pain coping 
strategies such as relaxation. This study failed to show that 
the cognitive treatment has any surplus value compared to 
group discussion. It is interesting that at post-treatment the 
EDI patients reported that they were less fearful than 
patients of the ECO condition. Five possible explanations 
for these findings can be put forward. First, because the 
same therapist conducted both the cognitive treatment and
the group discussion, “treatment contamination” could have 
taken place. To exclude this possible threat to internal valid­
ity, ten 5 minute audiotaped fragments o f the sessions were 
presented in random order to a group of independent behav­
ior therapists. They were requested to judge whether the 
fragment belonged to a cognitive treatment session or a 
group discussion, To assess interrater reliability, the kappa 
coefficient was calculated. With kappa = 0.73 (p < 0.0001) 
treatment contamination can be excluded. Second, the EDI 
condition was designed as an “attention control” or “place­
bo” for the cognitive treatment. As a consequence, no skills 
were taught, but other nonspecific characteristics, including 
the therapist and the use o f audiocassettes and homework 
assignments, were the same for both treatment conditions. 
On the other hand, it was necessary to make the EDI as cred­
ible as the ECO. Therefore, patients of the EDI condition 
were requested to prepare written materials and to present 
the contents to the other participants in a formal presenta­
tion. It is likely that this procedure worked with these fear­
ful patients as a form of graded exposure. The literature on 
fear and anxiety includes numerous studies that demonstrate 
the effectiveness of graded exposure to the fear stimulus as 
a powerful treatment for phobic disorders. Mean scores on 
the social phobia scale of the FSS-III-R decreased from 26.2 
to 22.3 (meaningful cutoff score = 26) for the EDI, and 
remained unchanged for the ECO condition (25.9 vs 26.7). 
Moreover, McCracken and Gross48 have shown that in 
patients with chronic low back pain, fear is negatively asso­
ciated with both pain coping and pain control. If this were 
true for patients with FM, the attention control acted as an 
active, rather than a devitalized treatment. Third, it is also 
possible that in the less structured group discussion, patients 
experienced more recognition and social support from each 
other than the patients who received the structured cognitive 
treatment. Fourth, the limited effectiveness of the ECO may 
be related to poor compliance. A retrospective analysis of 
the homework sheets that patients completed after each 
homework assignment showed that 38% of the patients who 
were contacted did not return their sheets, and that less than 
50% of the assignments of the remaining patients were com­
pleted. The outcome of a cognitive treatment depends on 
repeated practice, not only during the sessions, but also
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between sessions49. Given the low education level of the 
patients, it is likely that the exercises were too difficult for 
many patients, who therefore failed to complete the home­
work assignments. This would lead to poor performance and 
decreased self-efficacy beliefs, possibly limiting the effica­
cy of the treatment50,51. Finally, the interventions were 
designed to be of low cost, with minimal therapist interven­
tions. It is possible that not enough individual counseling 
was provided to these distressed patients. During the cogni­
tive treatment, patients were confronted with their pain 
experience, and focused on their own (problematic) situa­
tions. They may have become more aware of personal diffi­
culties and complaints for which they desired counseling, 
but no individual treatment possibilities were included in the 
program. Extra support was sought not so much in the men­
tal health care system but in traditional medical care, reflect­
ed in the higher health care utilization for the ECO group 
compared to the EDI patients (see Part II)16. The EDI 
patients may have received more support from their peers 
during the less structured group discussions, possibly lead­
ing to less health care consumption.
In conclusion, the lack of differential effects between the
2  treatment interventions may be attributable to different 
effects that emerged in the ECO and the EDI condition. The 
EDI was more effective than expected, because o f increased 
social support or because fear reduction might have 
enhanced pain coping and pain control. On the other hand, 
poor compliance, the difficulty of the homework assign­
ments, and lack o f individual support may have limited the 
effectiveness of the ECO condition. Confounding factors, 
such as selection bias, contamination bias, and differential 
treatment credibility, have been assessed and can be exclud­
ed. A limitation of this study is that only pain related and 
affective outcome variables have been chosen. No conclu­
sions can be made about improvements in disease process 
measures such as measures of fatigue, number of fibromyal­
gie tender points, and sleep ratings. In addition, it would be 
important to know whether cognitive-behavioral treatment 
leads to favorable changes on the patients’ global assess­
ment and on measures of functional status. For an econom­
ic evaluation and a quality of life assessment o f this study, 
the reader is referred to Part I I16.
Based on the current data, and given the promising 
results of the reports by Nielson, e t  a lu  and White and 
N ielson15 of more intensive inpatient cognitive-behavioral 
intervention, it seems justified to conclude that the outpa­
tient educational program, with or without cognitive treat­
ment, is too superficial to sufficiently meet the needs of dis­
abled patients with FM  in our study. It is very likely that the 
patients, who have an average o f 10 years’ disease duration, 
have developed entrenched pain behaviors, which would not 
be expected to change dramatically during an intervention 
that does not include some kind of individualized behavior 
modification technique52. Therefore, randomized clinical
trials are needed to assess the potential effectiveness of a 
cognitive treatment that is embedded in a more comprehen­
sive program including individual counseling, spouse 
involvement, and interventions that are aimed at fear reduc­
tion. The intervention we describe in this paper probably 
holds more promise for patients with recent pain onset and 
less severe pain behaviors.
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